Home Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?
 

Keywords :   


Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?

2015-02-18 11:29:09| Biotech - Topix.net

There will be around 130,000 new cases of colorectal cancer and close to 50,000 deaths due to colorectal cancer in the U.S. in 2015 alone. Cologuard from Exact Sciences is FDA approved and has a screening detection rate of 93% compared to closest competitor at 73%.

Tags: exact sciences cancer screening

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.07Atlantic Tropical Weather Outlook
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Public Advisory Number 13A
02.07Hurricane Beryl Graphics
02.07American Simmental Association announces Fall Focus 2024 in Amarillo, Texas
02.07Ribbon cutting celebrates new feedlot research, teaching, extension center
02.07Eastern North Pacific Tropical Weather Outlook
02.07The fastest data in the world
More »